PureTech Health plc (OTCMKTS:PTCHF – Get Free Report) shares were down 8.8% during trading on Tuesday . The stock traded as low as $1.55 and last traded at $1.55. Approximately 4,000 shares changed hands during trading, a decline of 72% from the average daily volume of 14,538 shares. The stock had previously closed at $1.70.
PureTech Health Trading Down 8.8%
The company has a fifty day simple moving average of $1.69 and a two-hundred day simple moving average of $1.69.
About PureTech Health
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
See Also
- Five stocks we like better than PureTech Health
- What is a SEC Filing?
- Why Taiwan Semiconductor’s 6.5% Dip Could Be a Smart Buy
- Dividend Capture Strategy: What You Need to Know
- RTX Surges to Record Highs as Defense Orders Explode
- Trading Halts Explained
- Smart Money Is Buying Auto Suppliers, Not Car Brands
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
